Learn more

CAMBRIDGE ANTIBODY TECH

Overview
  • Total Patents
    186
About

CAMBRIDGE ANTIBODY TECH has a total of 186 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PROTAB LTD, AFFITECH AS and PIERIS PROTEOLAB AG.

Patent filings per year

Chart showing CAMBRIDGE ANTIBODY TECHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Johnson Kevin Stuart 42
#2 Vaughan Tristan John 30
#3 Wilton Alison Jane 28
#4 Mccafferty John Gerald 26
#5 Winter Gregory Paul 22
#6 Tempest Philip Ronald 21
#7 Griffiths Andrew David 20
#8 Jackson Ronald Henry 19
#9 Pope Anthony Richard 17
#10 Thompson Julia Elizabeth 17

Latest patents

Publication Filing date Title
AU2013200665A1 Pseudomonas exotoxin a cd4+ t-cell epitopes
AU2011203351A1 Neutralizing Antibodies Against GDF-8 and Uses Therefor
WO2007099346A1 Binding members for ghrelin
GB0620934D0 Protein variants
WO2006072801A1 Method of mutagenesis
GB0519923D0 Interleukin-13 antibody composition
WO2005103076A2 Erythropoietin protein variants
GB0500417D0 Method of mutagenesis
GB0500099D0 Methods and means relating to protein variants
WO2005014800A1 Myeloma cell culture in transferrin-free low iron medium
MXPA06000258A Human antibody molecules for il-13.
GB0409122D0 Protein variants
GB0408219D0 Phage display assay
GB0407315D0 Human antibody molecules
US7261893B2 Neutralizing antibodies against GDF-8 and uses therefor
GB0318679D0 Cell culture
US2005049403A1 Human antibodies specific for TGFβ2
MXPA02012434A Antibodies that immunospecifically bind to blys.
EP1652919A1 Improvements to ribosome display
CA2402452A1 Improvements to ribosome display